Preferred Label : apalutamide;

MeSH note : an androgen receptor antagonist; structure in first source;

CISMeF synonym : ARN-509;

Is substance : O;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3471813/fr/erleada-apalutamide-cancer-de-la-prostate
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
Product containing only apalutamide in oral dose form (medicinal product form)
apalutamide
androgen receptor antagonists
Hormone-sensitive prostate cancer metastatic
Hormone sensitive prostate cancer (disorder)
evaluation of the transparency committee
apalutamide
prostatic neoplasms, Castration-Resistant

---
https://www.has-sante.fr/jcms/p_3191918/fr/erleada
2020
false
false
false
France
insurance, health, reimbursement
apalutamide
apalutamide
prostatic neoplasms
neoplasms, hormone-dependent
antineoplastic combined chemotherapy protocols
neoplasm metastasis
treatment outcome
adult
administration, oral
survival analysis
adenocarcinoma
evaluation of the transparency committee
thiohydantoins

---
https://www.ema.europa.eu/en/medicines/human/EPAR/erleada
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug approval
europe
apalutamide
apalutamide
product surveillance, postmarketing
apalutamide
adult
administration, oral
prostatic neoplasms, Castration-Resistant
aged
drug interactions
pregnancy
breast feeding
neoplasm metastasis
drug evaluation, preclinical
androgen receptor antagonists
androgen receptor antagonists
thiohydantoins
thiohydantoins

---
https://www.has-sante.fr/jcms/p_3076072/fr/erleada
2019
false
false
false
France
apalutamide
administration, oral
androgen receptor antagonists
prostatic neoplasms, Castration-Resistant
apalutamide
adult
treatment outcome
evaluation of the transparency committee
thiohydantoins

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00400
2018
false
false
false
Canada
French
drug information
drug evaluation
apalutamide
drug approval
canada
treatment outcome
product surveillance, postmarketing
administration, oral
prostatic neoplasms, Castration-Resistant
androgen receptor antagonists
androgen receptor antagonists
apalutamide
apalutamide
thiohydantoins
thiohydantoins
thiohydantoins

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.